SCHEMBL4243830

SCHEMBL4243830

c1ccc(Nc2nc(-c3cnn(CC4CCC4)c3)ns2)nc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.39
NPC1 O15118 4/20 0.38
RAB9A P51151 4/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
CASP3 P42574 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP7 Q9BQF6 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
LRRK2 Q5S007 1/20 0.36
TTK P33981 1/20 0.36
TBK1 Q9UHD2 2/20 0.36
BCHE P06276 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
PIK3CD O00329 1/20 0.35
PIK3CA P42336 1/20 0.35
PIK3CB P42338 1/20 0.35
PI4KA P42356 1/20 0.35
PIK3CG P48736 1/20 0.35
PI4KB Q9UBF8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4236523 0.96 EGFR (0.41) EGFRNPC1RAB9AMEN1KMT2A
Hydrochloric Acid SCHEMBL4234156 0.95 EGFR (0.41) EGFRNPC1RAB9AMEN1KMT2A
SCHEMBL4241653 0.91 JAK2 (0.40) EGFRNPC1RAB9AMEN1KMT2A
SCHEMBL4235797 0.83 KDR (0.40) NPC1RAB9AMEN1KMT2ACASP3
SCHEMBL4241649 0.82 GRK2 (0.40) NPC1RAB9AMEN1KMT2ACASP3
SCHEMBL4239760 0.81 MET (0.38) NPC1RAB9AMEN1KMT2ACASP3
SCHEMBL4241553 0.78 CREBBP (0.43) EGFRTTKPIK3CDPIK3CAPIK3CB
SCHEMBL4237571 0.76 EGFR (0.41) EGFRTTKADORA3PIK3CDPIK3CA
SCHEMBL4233124 0.76 NPC1 (0.36) NPC1RAB9AMEN1KMT2ACASP3
SCHEMBL4243041 0.76 SCD (0.43) ADORA3CDK5ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009010871-A2 PYRAZOLE DERIVATIVES AS ANTAGONISTS OF ADENOSINE A3 RECEPTOR ADDEX PHARMA S.A. (CH) 2009-01-22 WO disclosed